From: Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study
“Group A” (n = 30) | “Group B” (n = 60) | P value | |
---|---|---|---|
BPD (28 weeks) | 75.07 ± 3.61 | 75.03 ± 3.56 | 0.967 |
HC (28 weeks) | 261.67 ± 10.19 | 263.83 ± 10.32 | 0.348 |
FL (28 weeks) | 52.37 ± 2.74 | 52.38 ± 2.77 | 0.979 |
AC (28 weeks) | 235.77 ± 11.49 | 232.82 ± 15.29 | 0.309 |
EFW (28 weeks) | 1205.33 ± 112.68 | 1187.48 ± 144.86 | 0.556 |
Mean uterine PI (28 weeks) | 0.84 ± 0.15 | 0.85 ± 0.19 | 0.723 |
Umbilical PI (28 weeks) | 1.11 ± 0.19 | 1.15 ± 0.20 | 0.333 |
Amniotic fluid index | 13.67 ± 1.67 | 13.97 ± 2.33 | 0.531 |
Gross anomalies | 1 (3.33%) | 1 (1.67%) | 0.613 |